14.10.2010 11:00:00
|
IBM and ANTs Software to Showcase the IBM DB2 SQL Skin Innovation at Upcoming IBM Information On Demand Conference in Las Vegas, Nevada
ANTs software inc. (OTCBB: ANTS), a leader in database consolidation solutions, today announced that IBM and ANTs Software will showcase the IBM® DB2® SQL Skin for applications compatible with Sybase ASE (DB2 SQL Skin) at the upcoming IBM Information on Demand Conference in Las Vegas, October 24th through October 28th.
With six different sessions covering the current available product and three sessions covering future trends related to database migration, the conference provides a comprehensive agenda around the present and future of DB2 SQL Skin. As part of these sessions, Tom Holdener, Senior Technical Specialist of BJC HealthCare will host a presentation that offers an inside look at moving from a Sybase ASE environment to IBM DB2. The Conference is IBM’s premier global event for information management and is a must-attend for both business and IT professionals.
"We are thrilled that DB2 SQL Skin will have a very high level of exposure at this prestigious event,” commented Joseph Kozak, Chairman and Chief Executive Officer of ANTs Software. "The IBM Information On Demand Conference is a significant gathering of 9000 industry professionals and we are honored to be part of it. We look forward to meeting potential customers and showing the world that ANTs Software is an innovative force in the software industry and is well positioned for expansion.”
About ANTs software, inc.
ANTs software inc. is revolutionizing and simplifying DBMS migration, hardware consolidation and IT modernization. Our mission is to help customers efficiently use IT resources and drive down IT operating costs by consolidating hardware and software infrastructure. For more information, visit www.ants.com.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the federal securities laws, including statements concerning financial projections, financing activities, product development activities and sales and licensing activities. Such forward-looking statements are not guarantees of future results or performance, are sometimes identified by words of condition such as "should,” "could,” "expects,” "may,” or "intends,” and are subject to a number of risks and uncertainties, known and unknown, that could cause actual results to differ materially from those intended or anticipated. Such risks include, without limitation: problems securing the necessary financing to continue operations should revenues not be sufficient to offset expenses, problems encountered in commercializing the ANTs technology, potential of undetected infringing technology or non-infringing competitive technologies, difficulties experienced in product development, roadblocks experienced in sales and marketing activities, longer than expected sales processes, difficulties in recruiting knowledgeable and experienced personnel, possible problems in migrating applications using the ANTs Compatibility Server (ACS), and potential problems in protecting the Company’s intellectual property. Further information concerning these and other risks is included in the Company’s filings with the Securities and Exchange Commission, including the Company’s most recent Annual Report on Form 10-K for the fiscal year ended December 31, 2009. The Company undertakes no obligation to update or revise such forward-looking statements to reflect events or circumstances occurring after the date of this press release.
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu NanoViricides Incmehr Nachrichten
Keine Nachrichten verfügbar. |